FDA launches new priority review voucher program for select biopharmas

Capricor

Doctor working on iPad with hospital setting in background
Biotech

Capricor finds efficacy in older Duchenne patients in phase 2

Capricor Therapeutics’ Duchenne muscular dystrophy therapy appears to have slowed disease progression in older boys and young men.
Annalee Armstrong Sep 24, 2021 7:00am
DNA

Capricor yo-yos as J&J dumps stem cell partnership

Jul 7, 2017 9:58am